222 related articles for article (PubMed ID: 2538653)
1. The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.
Kenney S; Kamine J; Holley-Guthrie E; Lin JC; Mar EC; Pagano J
J Virol; 1989 Apr; 63(4):1729-36. PubMed ID: 2538653
[TBL] [Abstract][Full Text] [Related]
2. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle.
Rooney CM; Rowe DT; Ragot T; Farrell PJ
J Virol; 1989 Jul; 63(7):3109-16. PubMed ID: 2542618
[TBL] [Abstract][Full Text] [Related]
3. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
Zhang Q; Hong Y; Dorsky D; Holley-Guthrie E; Zalani S; Elshiekh NA; Kiehl A; Le T; Kenney S
J Virol; 1996 Aug; 70(8):5131-42. PubMed ID: 8764021
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
Le Roux F; Sergeant A; Corbo L
J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
[TBL] [Abstract][Full Text] [Related]
5. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
J Virol; 2017 May; 91(9):. PubMed ID: 28228591
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
Sista ND; Pagano JS; Liao W; Kenney S
Proc Natl Acad Sci U S A; 1993 May; 90(9):3894-8. PubMed ID: 8387200
[TBL] [Abstract][Full Text] [Related]
7. The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators.
Kenney S; Holley-Guthrie E; Mar EC; Smith M
J Virol; 1989 Sep; 63(9):3878-83. PubMed ID: 2548003
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
[TBL] [Abstract][Full Text] [Related]
9. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
[TBL] [Abstract][Full Text] [Related]
10. The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent.
Kenney S; Kamine J; Holley-Guthrie E; Mar EC; Lin JC; Markovitz D; Pagano J
J Virol; 1989 Sep; 63(9):3870-7. PubMed ID: 2548002
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
[TBL] [Abstract][Full Text] [Related]
12. Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP/BZLF1 plasmids.
Gradoville L; Grogan E; Taylor N; Miller G
Virology; 1990 Oct; 178(2):345-54. PubMed ID: 2171186
[TBL] [Abstract][Full Text] [Related]
13. Interaction of phospholipid scramblase 1 with the Epstein-Barr virus protein BZLF1 represses BZLF1-mediated lytic gene transcription.
Kusano S; Ikeda M
J Biol Chem; 2019 Oct; 294(41):15104-15116. PubMed ID: 31434743
[TBL] [Abstract][Full Text] [Related]
14. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
Hergenhahn M; Soto U; Weninger A; Polack A; Hsu CH; Cheng AL; Rösl F
Mol Carcinog; 2002 Mar; 33(3):137-45. PubMed ID: 11870879
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression.
Li Y; Webster-Cyriaque J; Tomlinson CC; Yohe M; Kenney S
J Virol; 2004 Apr; 78(8):4197-206. PubMed ID: 15047835
[TBL] [Abstract][Full Text] [Related]
16. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner.
Holley-Guthrie EA; Quinlivan EB; Mar EC; Kenney S
J Virol; 1990 Aug; 64(8):3753-9. PubMed ID: 2164595
[TBL] [Abstract][Full Text] [Related]
17. Expression of the BZLF1 latency-disrupting gene differs in standard and defective Epstein-Barr viruses.
Taylor N; Countryman J; Rooney C; Katz D; Miller G
J Virol; 1989 Apr; 63(4):1721-8. PubMed ID: 2538652
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein.
Nakayama S; Murata T; Murayama K; Yasui Y; Sato Y; Kudoh A; Iwahori S; Isomura H; Kanda T; Tsurumi T
J Biol Chem; 2009 Aug; 284(32):21557-68. PubMed ID: 19491105
[TBL] [Abstract][Full Text] [Related]
19. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication.
Li Y; Long X; Huang L; Yang M; Yuan Y; Wang Y; Delecluse HJ; Kuang E
J Virol; 2016 Jan; 90(2):887-903. PubMed ID: 26537683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]